Fluorescence, Reflectance, and Light-Scattering Spectroscopy for Evaluating Dysplasia in Patients With Barrett's Esophagus

Gastroenterology - United Kingdom
doi 10.1053/gast.2001.24842
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Affinity Peptide for Targeted Detection of Dysplasia in Barrett's Esophagus

Gastroenterology
HepatologyGastroenterology
2010English

Increased Expression and Secretion of Interleukin-6 in Patients With Barrett's Esophagus

Clinical Cancer Research
Cancer ResearchOncology
2004English

Mutagen Sensitivity and Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2006English

Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus

Gastroenterology
HepatologyGastroenterology
2011English

Session I: Barrett's Esophagus

Cancer Biomarkers
MedicineCancer ResearchOncologyGenetics
2006English

Barrett's Esophagus: Diagnosis and Management

Gastrointestinal Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2017English

Does the Treatment of Proton Pump Inhibitors Reduce Dysplasia or Adenocarcinoma Development in Barrett's Esophagus?

Turkish Journal of Gastroenterology
Gastroenterology
2017English

Endoscopic Eradication Therapy for Patients With Barrett’s Esophagus–associated Dysplasia and Intramucosal Cancer

Gastrointestinal Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2018English

CDX2, COX2 and MUC2 Expressions in Barrett's Esophagus: Can They Be Useful in Determination of the Dysplasia?

Turk Patoloji Dergisi
Forensic MedicinePathology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy